Journal: Nature Communications
Article Title: The mitochondrial type IB topoisomerase drives mitochondrial translation and carcinogenesis
doi: 10.1038/s41467-018-07922-3
Figure Lengend Snippet: TOP1MT promotes tumor growth. a Tumor growth of isogenic WT and TOP1MT knockout HCT116 xenografts as determined by caliper measurement. Cells (10,000) from two independent TOP1MT- deficient clones (KO1, n = 5; KO2, n = 9), a TOP1MT -expressing clone (WT ‡ , n = 3), which went through a mock CRISPR/Cas9 process, and the parental cell line (WT, n = 8) were injected subcutaneously in the flanks of female Ncr-nu/nu mice. b Weights of excised tumors were determined after 35 days (WT, KO2, n = 20; WT ‡ , n = 3; KO1, n = 8). c Representative bioluminescence imaging 35 days after transplantation of 10,000 cells of each type. d Quantification of the bioluminescence imaging. The total flux is plotted as photons per second (WT, n = 8; WT ‡ , n = 3; KO1, n = 9; KO2, n = 5). All data are means ± SEM; * p < 0.05, ** p < 0.01, *** p < 0.001, unpaired, two-tailed Student’s t -test
Article Snippet: Antibodies were obtained from the following sources (Supplementary Table ): abcam: OXPHOS Rodent (ab110413), OXPHOS (ab110411), Ki67 (ab16667); Cell Signaling Technologies: Akt (#4691S), p-Akt (#9271S), cleaved caspase 3 (#9661), GAPDH (#5174); Thermo Fisher Scientific: MRPS22 (#PA5-52249); MT-CO2 (#MS-1372-P1); DSHB: TOP1MT (#CPTC-TOP1-MT-3), A6 (#A6 BCM-s); Sigma-Aldrich: β-actin (#A5441), Santa Cruz: IgG (#sc-2027).
Techniques: Knock-Out, Clone Assay, Expressing, CRISPR, Injection, Imaging, Transplantation Assay, Two Tailed Test